Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

InVivoMAb Anti-Mouse CD3ε Antibody (145-2C11)

Catalog #:   VMC27702 Specific References (50) DATASHEET
Host species: Armenian hamster
Isotype: IgG1
Applications: ELISA, FCM, IF, In vitro T cell Stimulation/Activation, WB
Overview

Catalog No.

VMC27702

Species reactivity

Mouse

Host species

Armenian hamster

Isotype

IgG1

Clonality

Monoclonal

Target

T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, Cd3e, T-cell surface glycoprotein CD3 epsilon chain

Concentration

1 mg/ml

Endotoxin level

< 1 EU/mg as determined by LAL test.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Applications

ELISA, FCM, IF, In vitro T cell Stimulation/Activation, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

145-2C11

Data Image
References

T cell memory alters pulmonary inflammatory responses to cecal ligation and puncture., PMID:40475466

Development of a CD3ε mAb that can identify and in vitro activate T cells in large yellow croaker (Larimichthyscrocea)., PMID:40449701

Solution structure and synaptic analyses reveal determinants of bispecific T cell engager potency., PMID:40445758

Butyrate-producing bacteria in pregnancy maintenance: mitigating dysbiosis-induced preterm birth., PMID:40355924

Molecular Imaging of B7-H3-Targeting Bispecific T Cell-Engaging Antibody MGD009 in Glioblastoma Models., PMID:40183579

JNJ-78306358, a first-in-class bispecific T cell engaging antibody targeting CD3 and HLA-G., PMID:40060890

Allosteric Changes Underlie the Outside-In Transmission of Activatory Signals in the TCR., PMID:39754405

In situ staining with antibodies cross-reactive in pigs, cattle, and white-tailed deer facilitates understanding of biological tissue status and immunopathology., PMID:39719720

In situ cell-surface conformation of the TCR-CD3 signaling complex., PMID:39511422

Cis-interaction between CD52 and T cell receptor complex interferes with CD4+ T cell activation in acute decompensation of cirrhosis., PMID:39276679

Synthesis and Activity of T-Cell Tumor-Directing MegaMolecules., PMID:39167468

Structure of a fully assembled γδ T cell antigen receptor., PMID:39146975

Optimizing the Design and Geometry of T Cell-Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer., PMID:38638035

ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion., PMID:38614099

A pivotal decade for bispecific antibodies?, PMID:38465614

CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy., PMID:38437725

BR109, a Novel Fully Humanized T-Cell-Engaging Bispecific Antibody with GPRC5D Binding, Has Potent Antitumor Activities in Multiple Myeloma., PMID:38136320

Identification of novel targets for immunotherapies in subsets of patients with diffuse large B-cell lymphoma (DLBCL)., PMID:37964473

A PD-L1xCD3 bispecific nanobody as a novel T-cell engager in treating PD-L1 overexpression melanoma., PMID:37722180

Regulatory Rheumatoid Factor is Specific to PD-1 and Uses PD-1 Pathway to Control CD4 T Lymphocytes., PMID:37615124

CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression., PMID:37586770

Activation of T Lymphocytes with Anti-PDL1-BiTE in the Presence of Adipose-Derived Mesenchymal Stem Cells (ASCs)., PMID:39282109

Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma., PMID:37192303

NAV-003, a bispecific antibody targeting a unique mesothelin epitope and CD3ε with improved cytotoxicity against humoral immunosuppressed tumors., PMID:37146241

Development of Porcine Monoclonal Antibodies with In Vitro Neutralizing Activity against Classical Swine Fever Virus from C-Strain E2-Specific Single B Cells., PMID:37112845

Human Antibody VH Domains Targeting GPNMB and VCAM-1 as Candidate Therapeutics for Cancers., PMID:37067377

CD33 BiTE® molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells., PMID:37041225

Aberrant expression of T cell receptors in monocyte/macrophage RAW 264.7 cells: FCγRII/III compensates the need for CD3., PMID:37028131

Structure-based engineering of a novel CD3ε-targeting antibody for reduced polyreactivity., PMID:36991534

Lipid Nanoparticle Delivery System for mRNA Encoding B7H3-redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors., PMID:36403209

Platelet-derived TLT-1 promotes tumor progression by suppressing CD8+ T cells., PMID:36305874

Inverted direct allorecognition triggers early donor-specific antibody responses after transplantation., PMID:36130013

Spatial requirements for ITAM signaling in an intracellular natural killer cell model membrane., PMID:35933027

High-fat diet blunts T-cell responsiveness in Nile tilapia., PMID:35863514

Immunohistochemical analysis of the thymus in newborn and adult yaks (Bos grunniens)., PMID:35661993

TCR-mimic bispecific antibodies to target the HIV-1 reservoir., PMID:35394875

Differential activation of chicken gamma delta T cells from different tissues by Toll-like receptor 3 or 21 ligands., PMID:35271861

Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo model., PMID:35241687

Recent Advances in the Diagnosis and Treatment of Natural Killer Cell Malignancies., PMID:35158865

T cell activation and IFNγ modulate organ dysfunction in LPS-mediated inflammation., PMID:35141943

IgD ligation allows peritoneal cavity B cell proliferation., PMID:35077917

Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis., PMID:35045965

CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors., PMID:35039463

Structural arrangement of the VH and VL domains in the COBRA™ T-cell engaging single-chain diabody., PMID:35005430

Colorectal Cancer Progression Is Potently Reduced by a Glucose-Free, High-Protein Diet: Comparison to Anti-EGFR Therapy., PMID:34830971

Bispecific T-Cell Engagers Targeting Membrane-Bound IgE., PMID:34829798

Juzentaihoto Exerts Anti-Allergic Effects by Inhibiting Effector T-Cell Activation and Inducing and/or Activating Regulatory T Cells in a Murine Model of Contact Hypersensitivity., PMID:34818253

Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells., PMID:34725504

The role of IP-10 and its receptor CXCR3 in early pregnancy., PMID:34655920

Human Cytomegalovirus Infection Promotes Expansion of a Functionally Superior Cytoplasmic CD3+ NK Cell Subset with a Bcl11b-Regulated T Cell Signature., PMID:34625521

Datasheet
$ 302
Product specifications
100 μg 302 1 mg 1204

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

InVivoMAb Anti-Mouse CD3ε Antibody (145-2C11) [VMC27702]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only